We are live on ! Find out more
MOR

MorphoSys AG American Depositary Shares

Delisted

MOR was delisted on the 2nd of August, 2024.

26 hedge funds and large institutions have $21.7M invested in MorphoSys AG American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

54% less funds holding

Funds holding: 5626 (-30)

76% less call options, than puts

Call options by funds: $3.39M | Put options by funds: $14.4M

83% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 35

89% less capital invested

Capital invested by funds: $207M → $21.7M (-$185M)

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
26
Holders Change
-30
Holders Change %
-53.57%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
8
Reduced
9
Closed
35
Calls
$3.39M
Puts
$14.4M
Net Calls
-$11M
Net Calls Change
+$9.93M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$18.5M -$14.8K -815 -0.1%
HWAM
2
Hennion & Walsh Asset Management
New Jersey
$2.27M +$139K +7,644 +7%
EGM
3
Engineers Gate Manager
New York
$244K
AP
4
Advisors Preferred
Maryland
$118K +$103K +5,695 +705%
QCG
5
Quadrant Capital Group
Ohio
$108K +$5.6K +308 +5%
RhumbLine Advisers
6
RhumbLine Advisers
Massachusetts
$94.4K +$14.3K +785 +18%
Bank of America
7
Bank of America
North Carolina
$61.9K -$407K -22,409 -87%
UBS Group
8
UBS Group
Switzerland
$60.4K -$21.2M -1,164,695 -100%
S
9
SignatureFD
Georgia
$54.7K +$654 +36 +1%
GI
10
GAMMA Investing
California
$52.3K +$16.9K +931 +48%
Citigroup
11
Citigroup
New York
$38K -$52.9K -2,911 -58%
US Bancorp
12
US Bancorp
Minnesota
$35.8K +$8.58K +472 +32%
PA
13
Parallel Advisors
California
$27.2K
LC
14
Lindbrook Capital
California
$22.9K +$145 +8 +0.6%
NS
15
NBC Securities
Alabama
$12K
ECM
16
ExodusPoint Capital Management
New York
$8K -$1.47M -80,663 -99%
Wells Fargo
17
Wells Fargo
California
$7.28K -$30.7K -1,688 -81%
Morgan Stanley
18
Morgan Stanley
New York
$6.44K -$6.07M -334,078 -100%
FFA
19
Farther Finance Advisors
California
$5.67K +$5.67K +312 New
CL
20
CSS LLC
Illinois
$4.79K -$699K -38,487 -99%
BTI
21
Blue Trust Inc
Georgia
$1.65K +$1.65K +91 New
SAM
22
Smartleaf Asset Management
Massachusetts
$1.24K +$1.24K +68 New
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$1K -$2.33K -128 -64%
BIA
24
Bell Investment Advisors
California
$710 +$709 +39 New
CIBC Private Wealth Group
25
CIBC Private Wealth Group
Georgia
$205 +$200 +11 New

MOR Hedge Fund Activity: Q2 2024 in Review

26 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q2 2024, worth a combined $21.7M — down 89% from $207M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of MOR and 6 opened new positions — a net loss of 29 holders — while 9 trimmed existing stakes and 8 added.

The largest buyer was Hennion & Walsh Asset Management, adding an estimated $139K. The largest seller was Glazer Capital LLC, exiting entirely with an estimated $26.3M sold.

  • 26 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q2 2024, down from 56 in Q1 2024.
  • Funds reported $21.7M of MorphoSys AG American Depositary Shares stock for Q2 2024, down 89% quarter-over-quarter.
  • 6 funds opened new MorphoSys AG American Depositary Shares positions in Q2 2024 and 35 closed out, a net change of -29 holders.
  • The largest MorphoSys AG American Depositary Shares buyer in Q2 2024 was Hennion & Walsh Asset Management, an estimated $139K added.
  • The largest MorphoSys AG American Depositary Shares seller in Q2 2024 was Glazer Capital LLC, an estimated $26.3M sold.

Based on aggregated 13F filings for Q2 2024.